Abstract: Many experimental studies indicate that some antiepileptic drugs possess neuroprotective properties in varied models of neuronal injury. Levetiracetam is a second-generation antiepileptic drug with a novel mechanism of action. In the present study, we evaluated the putative neuroprotective effect of levetiracetam on primary hippocampal cultures at seven day in vitro. Cell death was induced by incubation of neural cultures in hypoxic conditions over 24 hours. Neuronal injury was assessed by morphometric investigation of death/total ratio of neurons in light microscopy using Trypan blue staining and by evaluation of lactate dehydrogenase (LDH) release in the culture medium. Our results indicate that pre-conditioning of hippocampal c...
PURPOSE: GABAA receptors from the brain of patients afflicted with mesial temporal lobe epilepsy (MT...
The word neurodegeneration rightly refers to the degenerative changes in nerve cell structure and so...
This study aimed to investigate the in vitro antioxidant activity of the novel anticonvulsant leveti...
Many experimental studies indicate that some antiepileptic drugs possess neuroprotective properties ...
PubMedID: 23266150Background: Hypoxic-ischemic brain injury (HIBI) is a common cause of neonatal mor...
The aim of this thesis was to evaluate plausible intracellular mechanisms of action for antiepilepti...
Introduction: Neuroinflammation is associated with the elevation of toxic proinflammatory mediators ...
The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, ce...
Introduction: The objective of our study is to compare the neuroprotective efficiency of Levetiracet...
AbstractPurposeLevetiracetam has been reported to be well tolerated and effective in status epilepti...
Epilepsy is a neurological seizure disorder that affects over 100 million people worldwide. Levetira...
The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, ce...
In this study we evaluated the neurotoxicity of eslicarbazepine acetate (ESL), and of its in vivo me...
Levetiracetam is a novel antiepileptic agent with a wide spectrum of activity against experimental a...
This study investigates the effects of levetiracetam (LEV) on the functional and structural properti...
PURPOSE: GABAA receptors from the brain of patients afflicted with mesial temporal lobe epilepsy (MT...
The word neurodegeneration rightly refers to the degenerative changes in nerve cell structure and so...
This study aimed to investigate the in vitro antioxidant activity of the novel anticonvulsant leveti...
Many experimental studies indicate that some antiepileptic drugs possess neuroprotective properties ...
PubMedID: 23266150Background: Hypoxic-ischemic brain injury (HIBI) is a common cause of neonatal mor...
The aim of this thesis was to evaluate plausible intracellular mechanisms of action for antiepilepti...
Introduction: Neuroinflammation is associated with the elevation of toxic proinflammatory mediators ...
The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, ce...
Introduction: The objective of our study is to compare the neuroprotective efficiency of Levetiracet...
AbstractPurposeLevetiracetam has been reported to be well tolerated and effective in status epilepti...
Epilepsy is a neurological seizure disorder that affects over 100 million people worldwide. Levetira...
The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, ce...
In this study we evaluated the neurotoxicity of eslicarbazepine acetate (ESL), and of its in vivo me...
Levetiracetam is a novel antiepileptic agent with a wide spectrum of activity against experimental a...
This study investigates the effects of levetiracetam (LEV) on the functional and structural properti...
PURPOSE: GABAA receptors from the brain of patients afflicted with mesial temporal lobe epilepsy (MT...
The word neurodegeneration rightly refers to the degenerative changes in nerve cell structure and so...
This study aimed to investigate the in vitro antioxidant activity of the novel anticonvulsant leveti...